Imre Pavo

基本信息

浏览量：100

职业迁徙

个人简介

Imre Pavo currently works at the Medical Department, Eli Lilly. Imre does research in Cardiology, Diabetology, Osteoporosis and Clinical Trials. Their current project is 'Type 2 diabetes therapies'.

研究兴趣

论文共 239 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Improved HbA1c and Body Weight in GADA-positive Individuals Treated with Tirzepatide: A Post Hoc Analysis of SURPASS

Anne L. Peters,Raffaella Buzzetti,Clare J. Lee,Imre Pavo,Minzhi Liu,Chrisanthi A. Karanikas,Jim S. Paik

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2024)

引用0浏览0WOS引用

Abstract 4142799: Central Role of LIM Domain Binding 3 (LDB3) Protein in Tetralogy of Fallot Assessed by Single-Nuclei Multiome Profiling of Paediatric Right Ventricular Samples

Mariann Gyongyosi,Emilie Han,Dominika Lukovic,Ena Hasimbegovic, Benjamen White, Artur Gynter, Veronika Mancikova,Imre Pavo,Ina Michel-Behnke

Circulationno. Suppl_1 (2024)

引用0浏览0引用

Reduction of Prevalence of Patients Meeting the Criteria for Metabolic Syndrome with Tirzepatide: a Post Hoc Analysis from the SURPASS Clinical Trial Program

Stephen J. Nicholls,Santiago Tofé,Carel W. le Roux,David A. D’Alessio,Russell J. Wiese,Imre Pavo,Katelyn Brown,Govinda J. Weerakkody,Meltem Zeytinoglu,Irene C. Romera

Cardiovascular Diabetologyno. 1 (2024)

引用0浏览0WOS引用

Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes

Qi Zou,Gunnar Engstrom,Jingxue Pan, Jialin Zhang, Esther J. Perisho, Yanzhu Lin,Russell Wiese, Jonathan M. Wilson,Imre Pavo, Rui Gao, Kevin L. Duffin,Yang De Marinis

DIABETES (2024)

引用0浏览0引用

741-P: Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes